Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.